- Home
- MRM vs ACON Comparison
MRM vs ACON Comparison
Compare MRM & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRM
- ACON
- Stock Information
- Founded
- MRM 2000
- ACON 2008
- Country
- MRM Japan
- ACON United States
- Employees
- MRM N/A
- ACON N/A
- Industry
- MRM Other Consumer Services
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- MRM Consumer Discretionary
- ACON Technology
- Exchange
- MRM Nasdaq
- ACON Nasdaq
- Market Cap
- MRM 5.9M
- ACON 4.8M
- IPO Year
- MRM 2020
- ACON 2022
- Fundamental
- Price
- MRM $1.60
- ACON $6.87
- Analyst Decision
- MRM
- ACON Buy
- Analyst Count
- MRM 0
- ACON 2
- Target Price
- MRM N/A
- ACON $481.00
- AVG Volume (30 Days)
- MRM 868.7K
- ACON 17.8K
- Earning Date
- MRM 05-20-2025
- ACON 05-15-2025
- Dividend Yield
- MRM N/A
- ACON N/A
- EPS Growth
- MRM 27.65
- ACON N/A
- EPS
- MRM 0.18
- ACON N/A
- Revenue
- MRM $52,786,758.00
- ACON $54,601.00
- Revenue This Year
- MRM N/A
- ACON $212.31
- Revenue Next Year
- MRM N/A
- ACON $92.86
- P/E Ratio
- MRM $9.10
- ACON N/A
- Revenue Growth
- MRM 21.55
- ACON N/A
- 52 Week Low
- MRM $0.34
- ACON $6.20
- 52 Week High
- MRM $8.39
- ACON $3,499.51
- Technical
- Relative Strength Index (RSI)
- MRM 63.18
- ACON 36.90
- Support Level
- MRM $1.48
- ACON $6.29
- Resistance Level
- MRM $1.75
- ACON $6.80
- Average True Range (ATR)
- MRM 0.28
- ACON 0.34
- MACD
- MRM 0.02
- ACON 0.88
- Stochastic Oscillator
- MRM 66.74
- ACON 65.17
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.